Article info
PDFResearch Article
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
- ↵a anna.laurell{at}akademiska.se
- ↵b maria.lonnemark{at}radiol.uu.se
- ↵c einar.brekkan{at}akademiska.se
- ↵d anders.magnussson{at}radiol.uu.se
- ↵e anna.tolf{at}akademiska.se
- ↵f annacarin.wallgren{at}karolinska.se
- ↵g bengt.a.andersson{at}vgregion.se
- ↵h lars.adamson{at}ki.se
- ↵i rolf.kiessling{at}ki.se
- ↵j alex.karlsson-parra{at}igp.uu.se alex.karlsson-parra{at}immunicum.com
Citation
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma
Publication history
- Received January 17, 2017
- Accepted June 2, 2017
- First published June 20, 2017.
Online issue publication
February 09, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© The Author(s).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.